Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BASELINE VARIABLES PREDICTING TREATMENT RESPONSE AT 6 MONTHS IN ADULT RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5MG BID IN A NON-INTERVENTIONAL SETTING (TREAT - RA)

NCT04079920 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04079920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04079920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BASELINE VARIABLES PREDICTING TREATMENT RESPONSE AT 6 MONTHS IN ADULT RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5MG BID IN A NON-INTERVENTIONAL SETTING (TREAT - RA)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 22, 2020
Completion date
February 8, 2023
Enrollment
198 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis